A U.K. team implanted a novel device in a child with Lennox-Gastaut Syndrome. Several neuromodulation vendors were on site at the recent American Diabetes Association meeting. The fund launched with $27 million in commitments. Patients in the trial of the wearable device performed well on the Hamilton Depression rating. Cala Health Bounces Back From Reimbursement Woes. Neuroengineering Researchers Attend InterfaceRice 2024. Carnegie Mellon University Raises its Profile in BCI Research.
June 2024 Issue
Researchers Expand Options for Epilepsy Neuromodulation
Neuromodulation Vendors Target Diabetes Pain
SCI Ventures Launched to Fund Startups Targeting Paralysis
Neurolief Reports Positive Results from Depression Trial
Vendor Profile
Conference Report
Research Institution Profile
Publishers Letter
Financial News
News Briefs
Research Highlights